Xilio Therapeutics, Inc. (XLO)

NASDAQ: XLO · IEX Real-Time Price · USD

1.080

+0.040 (3.85%)

At close: May 1, 2024, 4:00 PM

1.090

+0.010 (0.93%)

After-hours: May 1, 2024, 7:00 PM EDT

Xilio Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	40	15	74	440	-	-
Market Cap Growth	-	-79.50%	-83.19%	-	-	-
Enterprise Value	6	-19	-28	260	0	-30
PE Ratio	-0.20	-0.20	-0.84	-5.80	-	-
PB Ratio	1.08	0.41	0.70	2.37	-	-
P/FCF Ratio	-0.22	-0.22	-0.95	-5.37	-	-
P/OCF Ratio	-0.22	-0.22	-0.98	-5.44	-	-
EV/EBITDA Ratio	0.25	0.25	0.33	-3.51	-0.01	1.78
EV/EBIT Ratio	0.24	0.24	0.32	-3.44	-0.01	1.76
EV/FCF Ratio	0.27	0.27	0.36	-3.18	-0.01	1.64
Debt / Equity Ratio	0.34	0.34	0.19	0.11	-0.25	-0.63
Debt / EBITDA Ratio	-0.17	-0.17	-0.23	-0.28	-0.39	-1.09
Debt / FCF Ratio	-0.18	-0.18	-0.26	-0.25	-0.55	-1.00
Quick Ratio	2.90	2.90	5.77	15.62	0.94	9.42
Current Ratio	3.02	3.02	5.90	15.85	0.93	9.81
Return on Equity (ROE)	-126.60%	-126.60%	-65.10%	-148.40%	97.90%	-
Return on Assets (ROA)	-89.20%	-89.20%	-52.60%	-59.60%	-111.50%	-
Return on Capital (ROIC)	-160.41%	-160.41%	-70.99%	-36.44%	87.91%	174.69%
Earnings Yield	-191.66%	-504.38%	-119.38%	-17.25%	-	-
FCF Yield	-173.35%	-456.20%	-105.00%	-18.62%	-	-
Buyback Yield / Dilution	-0.38%	-0.38%	-388.59%	-970.34%	86.53%	-
Total Shareholder Return	-0.38%	-0.38%	-388.59%	-970.34%	86.53%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).